Clinical Relevance of Different Training Intensities in Chronic Heart Failure.

January 16, 2022 updated by: Heba Ahmed Ali Abdeen, Cairo University

Clinical Relevance and Prognostic Outcomes of Different Training Intensities for Cardiac Remodeling in Chronic Heart Failure.

To determine the efficacy of different aerobic exercise training intensities in patients with chronic heart failure.Forty five eligible male patients with chronic heart failure were randomly assigned into three groups( High intensity , moderate intensity and low intensity)groups .

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Forty five eligible male patients with chronic heart failure secondary to ischemic heart disease were selected from National Heart Institute heart failure outpatient clinic , their ages ranged from 50-60 years old and their ejection fraction ranged from 30-40% ,they were randomly assigned into three groups :HIT Group: received High Intensity aerobic Training in the form of bicycle ergometer exercise for the lower limbs three times /week for three months.(n=15) MIT Group: received moderate Intensity aerobic Training in the form of bicycle ergometer exercise for the lower limbs three times /week for three months. .(n=15) LIT Group: received low Intensity aerobic Training in the form of bicycle ergometer exercise for the lower limbs three times /week for three months, Before and after intervention, the following measures were obtained: Echocardiograph parameter (EF%, and left ventricular internal dimension ) , prognostic biomarkers (proBNP), and quality of life .

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 12316
        • Faculty of physical therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Patients with following criteria were included :

    • All patients ages were between 50 - 60 years old
    • Fractional shortening < 25% and ejection fraction < 40%
    • Sinus rhythm.
    • Heart Failure due to ischemic heart disease.
    • New York Heart Association (NYHA) class II-III.
    • Regular medical treatment.

Exclusion Criteria:

  • Patients with following criteria were excluded :

    • Chronic heart failure due to other causes
    • History of pulmonary disease (chronic obstructive lung disease, moderate to severe pulmonary hypertension).
    • Recent acute coronary syndrome or revascularization (3 months).
    • Exercise limited by angina or peripheral arterial occlusive disease;
    • Cerebrovascular or musculoskeletal disease preventing exercise testing or training.
    • Poorly controlled or exercise-induced cardiac arrhythmias
    • Logistic problems to attend regular exercise training sessions. Uncontrolled hypertension.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: High intensity aerobic training group(HIT)
15 patients who received High Intensity aerobic Training in the form of bicycle ergometer exercise for the lower limbs three times /week for three months.
bicycle ergometer exercise training
ACTIVE_COMPARATOR: Moderate intensity aerobic training group(MIT)
15 patients who received moderate Intensity aerobic Training in the form of bicycle ergometer exercise for the lower limbs three times /week for three months.
bicycle ergometer exercise training
ACTIVE_COMPARATOR: Low intensity aerobic training group(LIT)
15 patients who received low Intensity aerobic Training in the form of bicycle ergometer exercise for the lower limbs three times /week for three months
bicycle ergometer exercise training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ejection fraction
Time Frame: change from baseline to after 12 weeks
represents left ventricular function measured by pulsed echocardiography
change from baseline to after 12 weeks
pro-brain natriuretic peptide (proBNP)
Time Frame: change from baseline to after 12 weeks
biomarker for heart failure measured by analysis of venous samples drawn
change from baseline to after 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Minnesota Living With Heart Failure Questionnaire (MLWHF):
Time Frame: change from baseline to after 12 weeks
Questionnaire for measuring quality of life of heart failure patients
change from baseline to after 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heba Ahmed Abdeen, PhD, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2020

Primary Completion (ACTUAL)

September 12, 2021

Study Completion (ACTUAL)

October 1, 2021

Study Registration Dates

First Submitted

January 16, 2022

First Submitted That Met QC Criteria

January 16, 2022

First Posted (ACTUAL)

January 28, 2022

Study Record Updates

Last Update Posted (ACTUAL)

January 28, 2022

Last Update Submitted That Met QC Criteria

January 16, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HF2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Heart Failure

Clinical Trials on Aerobic exercise training

3
Subscribe